Product Information
RINVOQ ER 30 MG TABLET is a brand product labeled by AbbVie Inc., priced at $228.7721 per EA under NDC 00074231030. Its NADAC has been published 115 times since Apr 17, 2024.
Strength
30 mg/1
Manufacturer
AbbVie Inc.NDC
00074231030
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
UPADACITINIBApproval Type
New Drug (NDA)
FDA Application
NDA211675On Market Since
8/16/2019
Pharmacological Classes
Price Statistics
The NADAC for RINVOQ ER 30 MG TABLET has been published 115 times since Apr 17, 2024, and over the history we have for it it has risen 10.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $228.7721 per EA |
|---|---|
| All-time high | $228.8254 (May 13, 2026) |
| All-time low | $206.7811 (Jul 17, 2024) |
| 52-week high | $228.8254 |
| 52-week low | $217.9290 |
| Median price | $217.9290 |
| Average price | $216.6425 |
| Largest weekly change | +5.0% (Jan 14, 2026) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Upadacitinib market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of RINVOQ ER 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RINVOQ ER 30 MG TABLET, manufactured by AbbVie Inc., is $228.7721 per EA (NDC 00074231030), effective Jun 24, 2026.
How has the price of RINVOQ ER 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for RINVOQ ER 30 MG TABLET has risen 10.6%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for RINVOQ ER 30 MG TABLET?
Since Apr 17, 2024, the NADAC for RINVOQ ER 30 MG TABLET has ranged from a low of $206.7811 (Jul 17, 2024) to a high of $228.8254 (May 13, 2026), with a median of $217.9290 per EA.
Are there cheaper alternatives to RINVOQ ER 30 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of RINVOQ ER 30 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures RINVOQ ER 30 MG TABLET?
RINVOQ ER 30 MG TABLET (NDC 00074231030) is labeled by AbbVie Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification